Drug intelligence / Profile preview

BTPA-Ma

Development stage
Preclinical
Lead developer
Qilu Hospital of Shandong University
Modality
Small Molecules
01

Overview

BTPA-Ma is a mitochondria-targeted, triphenylamine-bridged bis-boronate small molecule designed for the dual-mode treatment of bladder cancer [P0657]. Developed by Shandong University and Qilu Hospital of Shandong University, BTPA-Ma exhibits context-dependent, bidirectional regulation of reactive oxygen species (ROS) [P0657]. Under white light irradiation, BTPA-Ma acts as a photosensitizer, triggering a massive ROS storm that causes mitochondrial rupture, endoplasmic reticulum stress via the PERK-EIF2α pathway, and immunogenic cell death (ICD) [P0657]. In the absence of light (dark conditions), BTPA-Ma functions as a ROS scavenger, gradually consuming intrinsic ROS in tumor cells, which upregulates PTEN and inhibits the PI3K-AKT proliferative pathway [P0657]. This dual functionality allows BTPA-Ma to suppress tumor growth and remodel the immunosuppressive tumor microenvironment [P0657].

Other names
triphenylamine-bridged bis-boronate probe

Beyond the preview

Go deeper on BTPA-Ma.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BTPA-Ma.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call